News | Angiography | April 06, 2022

Dixon GRE Technique Outperforms Clinical Standard for Unenhanced Coronary MRA

Study included 44 patients with intermediate-to-high risk of coronary artery disease who underwent both 1.5-T SSFP and 3-T Dixon GRE coronary MRA examinations before coronary angiography.

According to ARRS’ American Journal of Roentgenology (AJR), the 3-T Dixon gradient-recalled echo (GRE) sequence performed higher than the current standard of 1.5-T SSFP for unenhanced coronary MRA, which could help expand clinical adoption of the procedure.

A 60-year-old man with chest pain. (A) Image from coronary angiogram shows no significant stenosis of right coronary artery (RCA). (B) Curved multiplanar reformatted image from 1.5-T SSFP coronary MRA shows severe stenosis of mid RCA (arrow), representing a false-positive finding. (C) Curved multiplanar reformatted image from 3-T Dixon GRE coronary MRA shows no RCA stenosis.


April 6, 2022 – According to ARRS’ American Journal of Roentgenology (AJR), the 3-T Dixon gradient-recalled echo (GRE) sequence performed higher than the current standard of 1.5-T SSFP for unenhanced coronary MRA, which could help expand clinical adoption of the procedure.

“For unenhanced coronary MRA, 3-T unenhanced Dixon GRE had better image quality and diagnostic performance than 1.5-T SSFP, particularly for distal and branch segments,” wrote lead researcher Hang Jin from China’s Fudan University and Shanghai Institute of Medical Imaging.

Jin and team’s prospective study included 44 patients (27 men, 17 women; mean age, 59 years) with intermediate-to-high risk of coronary artery disease who underwent both 1.5-T SSFP and 3-T Dixon GRE coronary MRA examinations before coronary angiography. Two radiologists independently assessed coronary arteries in random order for subjective image quality, number of visible segments, apparent contrast-to-noise ratio, and presence of significant stenoses.

Compared with 1.5-T SSFP, coronary MRA using 3-T unenhanced Dixon GRE demonstrated higher image quality (4.0±1.1 vs 3.0±1.2), higher percentage of visible coronary segments (96.7% vs 88.9%), as well as higher sensitivity (87.9% vs 77.3%) and specificity (83.3% vs 60.6%) for significant stenoses on a per-vessel basis, using coronary angiography as reference.

“The present results demonstrate the benefits of robust epicardial fat suppression using Dixon GRE in terms of improved apparent contrast-to-noise and improved visibility, with the latter difference observed particularly for distal and branch segments that course close to the myocardium,” the authors of this AJR article concluded.

Reference:

Unenhanced Whole-Heart Coronary MRA: Prospective Intraindividual Comparison of 1.5-T SSFP and 3-T Dixon Water-Fat Separation GRE Methods Using Coronary Angiography as Reference
 


Related Content

News | Cardiovascular Clinical Studies

October 14, 2022 — Heart Initiative, the sponsor of the STRONG-HF (Safety, Tolerability and efficacy of Rapid ...

Home October 14, 2022
Home
News | Cardiovascular Clinical Studies

October 11, 2022 — The preliminary results of the first-in-human (FIH) trials for the innovative ELANA Heart Bypass ...

Home October 11, 2022
Home
News | Cardiovascular Clinical Studies

October 4, 2022 — Lexicon Pharmaceuticals, Inc. announced that a new analysis of results from the SOLOIST-WHF Phase ...

Home October 04, 2022
Home
News | Cardiovascular Clinical Studies

September 8, 2022 — A clinical trial led by investigators from Brigham and Women’s Hospital has found that the long-term ...

Home September 08, 2022
Home
News | Cardiovascular Clinical Studies

August 17, 2022 — A study carried out by scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) ...

Home August 17, 2022
Home
News | Cardiovascular Clinical Studies

August 12, 2022 — Older adults with atrial cardiopathy (a major, often undetected cardiac cause of stroke) may be at ...

Home August 12, 2022
Home
News | Cardiovascular Clinical Studies

August 8, 2022 — Two years ago, University of Alabama at Birmingham researchers and colleagues reported that reductive ...

Home August 08, 2022
Home
News | Cardiovascular Clinical Studies

July 22, 2022 — BioSig Technologies, Inc. a medical technology company advancing electrophysiology workflow by ...

Home July 22, 2022
Home
News | Cardiovascular Clinical Studies

July 18, 2022 — scPharmaceuticals Inc., a pharmaceutical company focused on developing and commercializing products that ...

Home July 19, 2022
Home
News | Cardiovascular Clinical Studies

July 15, 2022 — Imagine, if scientists had a map of the heart, so granular in its accuracy that it even profiled details ...

Home July 15, 2022
Home
Subscribe Now